Other reports described more specific clinical features in LRRK2 carriers such as a lower limb onset [34], more hallucinations, behavioral disorders, and dopaminergic dysregulation syndrome [36, 38, 44] but less cognitive impairment [34, 36, 45]. Here, LRRK2 is linked to Cognitive impairment.